Track topics on Twitter Track topics that are important to you
The post FDA withdraws Eisai’s weight management drug Belviq due to cancer risk appeared first on Pharmaceutical Technology.
Original Article: FDA withdraws Eisai’s weight management drug Belviq due to cancer riskNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...